European Commission Approves Celltrion’s Stelara Biosimilar
Celltrion Joins The Likes Of Amgen, Sandoz And Stada In Europe
The European Commission followed the CHMP’s opinion and fully approved Celltrion’s Stelara biosimilar Steqeyma, making this the fourth approved Stelara rival in the bloc.
